PIII P3 Health Partners Inc.
Services-Health Services · Nasdaq · SEC CIK 1832511 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.5%
TTM net income YoY60.9%
TTM EPS YoY47.3%
Revenue 3-yr CAGR9.7%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-5.2%
Net margin-3.3%
FCF margin—
EBITDA margin0.2%
Returns
ROE-115.7%
ROA-7.6%
ROIC (approx.)-33.7%
Asset turnover2.30x
Leverage & solvency
Liabilities / assets70.0%
Debt / equity1.14x
Current ratio0.53x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.26x
Accruals ratio9.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20242025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.46B | $1.50B |
| SG&A expense | $106.31M | $112.60M |
| Operating income | -$270.30M | -$320.66M |
| Pretax income | -$321.06M | -$305.99M |
| Income tax | $2.02M | $4.39M |
| Net income | -$147.95M | -$135.85M |
| EBITDA | -$186.14M | -$234.60M |
| EPS (basic) | -45.26 | -46.78 |
| EPS (diluted) | -45.26 | -54.06 |
| Weighted avg. shares (diluted) | 3.27M | 2.94M |
| Banking | ||
| Net interest income | -$55.03M | -$22.17M |
| Provision for credit losses | $3.00M | $0 |
| Balance sheet | ||
| Cash & equivalents | $25.01M | $44.10M |
| Current assets | $133.08M | $184.14M |
| PP&E, net | $3.37M | $5.73M |
| Intangibles | $492.42M | $574.35M |
| Total assets | $656.64M | $783.42M |
| Current liabilities | $545.26M | $496.42M |
| Short-term debt | $45.04M | $75.16M |
| Long-term debt | $228.37M | $108.91M |
| Total debt | $273.41M | $184.06M |
| Total liabilities | $796.88M | $633.89M |
| Shareholders' equity | -$155.23M | $75.94M |
| Net debt | $248.40M | $139.96M |
| Cash flow statement | ||
| Operating cash flow | -$91.24M | -$110.13M |
| Capital expenditure | — | $0 |
| Free cash flow | — | -$110.13M |
| Investing cash flow | $129,000 | $14.53M |
| Financing cash flow | $72.81M | $98.77M |
| Depreciation & amortization | $84.16M | $86.06M |
| Stock-based compensation | $5.58M | $5.75M |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.